BF Biosciences introduces Sibionics CGM devices in Pakistan
BF Biosciences Limited (PSX: BFBIO) has introduced Continuous Glucose Monitoring (CGM) devices in Pakistan in collaboration with SIBIONICS, China, a medical technology company specializing in continuous glucose monitoring and digital health solutions
August 20, 2026 (MLN): BF Biosciences Limited (PSX: BFBIO) has introduced Continuous Glucose Monitoring (CGM) devices in Pakistan in collaboration with SIBIONICS, China, a medical technology company specializing in continuous glucose monitoring and digital health solutions. The devices are being introduced in Pakistan under the brand name Sibionics CGM. Founded in 2015, SIBIONICS has developed a global presence in C...